KO-MED CK is a company that has launched and developed clinical study sites for sponsors, industry investors, and financial institutions consolidating the clinical research market in the SMO and CRO sectors. We are one of the most experienced entities in Europe in this segment with a proven track record of success. We boast an excellent reputation in our field, confirmed by numerous audits.

We have a proven track record of creating value, as evidenced by the development and sale of a spun-off part of the company to Velocity (USA), a global leader in clinical research.

What sets us apart:

Effective performance and delivery on commitments. Excellent knowledge of the European market and its barriers. Experience in implementing business solutions on the European market. Contracting resources in Europe that meet the criteria of companies from other geographic markets, primarily from the USA.


We have a management system that takes into account legal, cultural, and geographical differences and IT systems adapted to them. We implement the enterprise architecture to the conditions existing on the European market (business model, strategy, operational models, contact models, billing models, participant recruitment models, research team employment model) enabling the achievement of excellent results.

Ready for European expansion?

Contact us today at to discuss your needs
and find out how we can help you achieve your goals.

Find Us On